PDB Short entry for 3OCB HEADER TRANSFERASE 09-AUG-10 3OCB TITLE AKT1 KINASE DOMAIN WITH PYRROLOPYRIMIDINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1 (AKT1); COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (RESIDUES 144-480); COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: GSK 3 BETA PEPTIDE; COMPND 9 CHAIN: C, D; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKT1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES KEYWDS SERINE-THREONINE KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.H.MORALES,G.P.A.VIGERS,B.J.BRANDHUBER REVDAT 2 29-SEP-10 3OCB 1 JRNL REVDAT 1 15-SEP-10 3OCB 0 JRNL AUTH J.F.BLAKE,N.C.KALLAN,D.XIAO,R.XU,J.R.BENCSIK,N.J.SKELTON, JRNL AUTH 2 K.L.SPENCER,I.S.MITCHELL,R.D.WOESSNER,S.L.GLOOR,T.RISOM, JRNL AUTH 3 S.D.GROSS,M.MARTINSON,T.H.MORALES,G.P.VIGERS,B.J.BRANDHUBER JRNL TITL DISCOVERY OF PYRROLOPYRIMIDINE INHIBITORS OF AKT. JRNL REF BIOORG.MED.CHEM.LETT. V. 20 5607 2010 JRNL REFN ISSN 0960-894X JRNL PMID 20810279 JRNL DOI 10.1016/J.BMCL.2010.08.053 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 22103 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1124 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.77 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1527 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.3080 REMARK 3 BIN FREE R VALUE SET COUNT : 83 REMARK 3 BIN FREE R VALUE : 0.4330 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5364 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 99 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.67000 REMARK 3 B22 (A**2) : -0.46000 REMARK 3 B33 (A**2) : 0.20000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.85000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.386 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.284 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.769 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.864 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5552 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7472 ; 1.240 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 650 ; 5.845 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 270 ;34.674 ;23.333 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 994 ;17.753 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 40 ;19.855 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 776 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4220 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3254 ; 0.473 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5234 ; 0.907 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2298 ; 1.107 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2238 ; 1.957 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3OCB COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-AUG-10. REMARK 100 THE RCSB ID CODE IS RCSB060935. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAY-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : RIGAKU/OSMIC MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23237 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.18700 REMARK 200 R SYM (I) : 0.15400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.44800 REMARK 200 R SYM FOR SHELL (I) : 0.36800 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 4000, 100MM HEPES, 10% REMARK 280 ISOPROPANOL, 10 MG/ML AKT1 KINASE DOMAIN, 0.6 MM GSK 3 BETA REMARK 280 PEPTIDE, PH 7.5, UNDER OIL, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 28.00650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 140 REMARK 465 ALA A 141 REMARK 465 MET A 142 REMARK 465 ALA A 143 REMARK 465 ILE A 447 REMARK 465 THR A 448 REMARK 465 ILE A 449 REMARK 465 THR A 450 REMARK 465 PRO A 451 REMARK 465 PRO A 452 REMARK 465 ASP A 453 REMARK 465 GLN A 454 REMARK 465 ASP A 455 REMARK 465 ASP A 456 REMARK 465 SER A 457 REMARK 465 MET A 458 REMARK 465 GLU A 459 REMARK 465 CYS A 460 REMARK 465 VAL A 461 REMARK 465 ASP A 462 REMARK 465 SER A 463 REMARK 465 GLU A 464 REMARK 465 ARG A 465 REMARK 465 THR A 479 REMARK 465 ALA A 480 REMARK 465 GLY B 140 REMARK 465 ALA B 141 REMARK 465 MET B 142 REMARK 465 ALA B 143 REMARK 465 PRO B 451 REMARK 465 PRO B 452 REMARK 465 ASP B 453 REMARK 465 GLN B 454 REMARK 465 ASP B 455 REMARK 465 ASP B 456 REMARK 465 SER B 457 REMARK 465 MET B 458 REMARK 465 GLU B 459 REMARK 465 CYS B 460 REMARK 465 VAL B 461 REMARK 465 ASP B 462 REMARK 465 SER B 463 REMARK 465 GLU B 464 REMARK 465 ARG B 465 REMARK 465 THR B 479 REMARK 465 ALA B 480 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 153 -60.90 -91.63 REMARK 500 ARG A 243 -60.87 66.17 REMARK 500 LYS A 268 -25.66 64.62 REMARK 500 ARG A 273 -17.97 74.78 REMARK 500 ASP A 292 80.21 66.85 REMARK 500 ASP A 302 -100.38 171.69 REMARK 500 ASP A 323 41.09 -93.22 REMARK 500 ASP A 398 -133.28 56.07 REMARK 500 GLN A 428 55.16 -99.95 REMARK 500 ALA A 444 48.03 -88.14 REMARK 500 GLN A 445 -6.75 60.26 REMARK 500 SER A 477 -132.49 -95.86 REMARK 500 LEU B 153 -64.91 -101.36 REMARK 500 ARG B 243 -57.04 69.63 REMARK 500 LYS B 268 -21.85 80.53 REMARK 500 ARG B 273 -22.64 75.11 REMARK 500 ASP B 292 102.27 65.57 REMARK 500 ASP B 302 -119.09 42.35 REMARK 500 ASP B 323 68.61 -107.10 REMARK 500 ASP B 325 147.65 76.00 REMARK 500 ASP B 398 -130.88 63.79 REMARK 500 THR B 430 -74.03 -64.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XM1 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XM1 B 2 DBREF 3OCB A 144 480 UNP B2RAM5 B2RAM5_HUMAN 144 480 DBREF 3OCB B 144 480 UNP B2RAM5 B2RAM5_HUMAN 144 480 DBREF 3OCB C 1 10 PDB 3OCB 3OCB 1 10 DBREF 3OCB D 1 10 PDB 3OCB 3OCB 1 10 SEQADV 3OCB GLY A 140 UNP B2RAM5 EXPRESSION TAG SEQADV 3OCB ALA A 141 UNP B2RAM5 EXPRESSION TAG SEQADV 3OCB MET A 142 UNP B2RAM5 EXPRESSION TAG SEQADV 3OCB ALA A 143 UNP B2RAM5 EXPRESSION TAG SEQADV 3OCB ASP A 473 UNP B2RAM5 SER 473 ENGINEERED MUTATION SEQADV 3OCB GLY B 140 UNP B2RAM5 EXPRESSION TAG SEQADV 3OCB ALA B 141 UNP B2RAM5 EXPRESSION TAG SEQADV 3OCB MET B 142 UNP B2RAM5 EXPRESSION TAG SEQADV 3OCB ALA B 143 UNP B2RAM5 EXPRESSION TAG SEQADV 3OCB ASP B 473 UNP B2RAM5 SER 473 ENGINEERED MUTATION SEQRES 1 A 341 GLY ALA MET ALA ARG VAL THR MET ASN GLU PHE GLU TYR SEQRES 2 A 341 LEU LYS LEU LEU GLY LYS GLY THR PHE GLY LYS VAL ILE SEQRES 3 A 341 LEU VAL LYS GLU LYS ALA THR GLY ARG TYR TYR ALA MET SEQRES 4 A 341 LYS ILE LEU LYS LYS GLU VAL ILE VAL ALA LYS ASP GLU SEQRES 5 A 341 VAL ALA HIS THR LEU THR GLU ASN ARG VAL LEU GLN ASN SEQRES 6 A 341 SER ARG HIS PRO PHE LEU THR ALA LEU LYS TYR SER PHE SEQRES 7 A 341 GLN THR HIS ASP ARG LEU CYS PHE VAL MET GLU TYR ALA SEQRES 8 A 341 ASN GLY GLY GLU LEU PHE PHE HIS LEU SER ARG GLU ARG SEQRES 9 A 341 VAL PHE SER GLU ASP ARG ALA ARG PHE TYR GLY ALA GLU SEQRES 10 A 341 ILE VAL SER ALA LEU ASP TYR LEU HIS SER GLU LYS ASN SEQRES 11 A 341 VAL VAL TYR ARG ASP LEU LYS LEU GLU ASN LEU MET LEU SEQRES 12 A 341 ASP LYS ASP GLY HIS ILE LYS ILE THR ASP PHE GLY LEU SEQRES 13 A 341 CYS LYS GLU GLY ILE LYS ASP GLY ALA THR MET LYS TPO SEQRES 14 A 341 PHE CYS GLY THR PRO GLU TYR LEU ALA PRO GLU VAL LEU SEQRES 15 A 341 GLU ASP ASN ASP TYR GLY ARG ALA VAL ASP TRP TRP GLY SEQRES 16 A 341 LEU GLY VAL VAL MET TYR GLU MET MET CYS GLY ARG LEU SEQRES 17 A 341 PRO PHE TYR ASN GLN ASP HIS GLU LYS LEU PHE GLU LEU SEQRES 18 A 341 ILE LEU MET GLU GLU ILE ARG PHE PRO ARG THR LEU GLY SEQRES 19 A 341 PRO GLU ALA LYS SER LEU LEU SER GLY LEU LEU LYS LYS SEQRES 20 A 341 ASP PRO LYS GLN ARG LEU GLY GLY GLY SER GLU ASP ALA SEQRES 21 A 341 LYS GLU ILE MET GLN HIS ARG PHE PHE ALA GLY ILE VAL SEQRES 22 A 341 TRP GLN HIS VAL TYR GLU LYS LYS LEU SER PRO PRO PHE SEQRES 23 A 341 LYS PRO GLN VAL THR SER GLU THR ASP THR ARG TYR PHE SEQRES 24 A 341 ASP GLU GLU PHE THR ALA GLN MET ILE THR ILE THR PRO SEQRES 25 A 341 PRO ASP GLN ASP ASP SER MET GLU CYS VAL ASP SER GLU SEQRES 26 A 341 ARG ARG PRO HIS PHE PRO GLN PHE ASP TYR SER ALA SER SEQRES 27 A 341 SER THR ALA SEQRES 1 B 341 GLY ALA MET ALA ARG VAL THR MET ASN GLU PHE GLU TYR SEQRES 2 B 341 LEU LYS LEU LEU GLY LYS GLY THR PHE GLY LYS VAL ILE SEQRES 3 B 341 LEU VAL LYS GLU LYS ALA THR GLY ARG TYR TYR ALA MET SEQRES 4 B 341 LYS ILE LEU LYS LYS GLU VAL ILE VAL ALA LYS ASP GLU SEQRES 5 B 341 VAL ALA HIS THR LEU THR GLU ASN ARG VAL LEU GLN ASN SEQRES 6 B 341 SER ARG HIS PRO PHE LEU THR ALA LEU LYS TYR SER PHE SEQRES 7 B 341 GLN THR HIS ASP ARG LEU CYS PHE VAL MET GLU TYR ALA SEQRES 8 B 341 ASN GLY GLY GLU LEU PHE PHE HIS LEU SER ARG GLU ARG SEQRES 9 B 341 VAL PHE SER GLU ASP ARG ALA ARG PHE TYR GLY ALA GLU SEQRES 10 B 341 ILE VAL SER ALA LEU ASP TYR LEU HIS SER GLU LYS ASN SEQRES 11 B 341 VAL VAL TYR ARG ASP LEU LYS LEU GLU ASN LEU MET LEU SEQRES 12 B 341 ASP LYS ASP GLY HIS ILE LYS ILE THR ASP PHE GLY LEU SEQRES 13 B 341 CYS LYS GLU GLY ILE LYS ASP GLY ALA THR MET LYS TPO SEQRES 14 B 341 PHE CYS GLY THR PRO GLU TYR LEU ALA PRO GLU VAL LEU SEQRES 15 B 341 GLU ASP ASN ASP TYR GLY ARG ALA VAL ASP TRP TRP GLY SEQRES 16 B 341 LEU GLY VAL VAL MET TYR GLU MET MET CYS GLY ARG LEU SEQRES 17 B 341 PRO PHE TYR ASN GLN ASP HIS GLU LYS LEU PHE GLU LEU SEQRES 18 B 341 ILE LEU MET GLU GLU ILE ARG PHE PRO ARG THR LEU GLY SEQRES 19 B 341 PRO GLU ALA LYS SER LEU LEU SER GLY LEU LEU LYS LYS SEQRES 20 B 341 ASP PRO LYS GLN ARG LEU GLY GLY GLY SER GLU ASP ALA SEQRES 21 B 341 LYS GLU ILE MET GLN HIS ARG PHE PHE ALA GLY ILE VAL SEQRES 22 B 341 TRP GLN HIS VAL TYR GLU LYS LYS LEU SER PRO PRO PHE SEQRES 23 B 341 LYS PRO GLN VAL THR SER GLU THR ASP THR ARG TYR PHE SEQRES 24 B 341 ASP GLU GLU PHE THR ALA GLN MET ILE THR ILE THR PRO SEQRES 25 B 341 PRO ASP GLN ASP ASP SER MET GLU CYS VAL ASP SER GLU SEQRES 26 B 341 ARG ARG PRO HIS PHE PRO GLN PHE ASP TYR SER ALA SER SEQRES 27 B 341 SER THR ALA SEQRES 1 C 10 GLY ARG PRO ARG THR THR SER PHE ALA GLU SEQRES 1 D 10 GLY ARG PRO ARG THR THR SER PHE ALA GLU MODRES 3OCB TPO A 308 THR PHOSPHOTHREONINE MODRES 3OCB TPO B 308 THR PHOSPHOTHREONINE HET TPO A 308 11 HET TPO B 308 11 HET XM1 A 1 28 HET XM1 B 2 28 HETNAM TPO PHOSPHOTHREONINE HETNAM XM1 (2S)-2-(4-CHLOROBENZYL)-3-OXO-3-[4-(7H-PYRROLO[2,3- HETNAM 2 XM1 D]PYRIMIDIN-4-YL)PIPERAZIN-1-YL]PROPAN-1-AMINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 5 XM1 2(C20 H23 CL N6 O) FORMUL 7 HOH *99(H2 O) HELIX 1 1 THR A 146 ASN A 148 5 3 HELIX 2 2 LYS A 183 LYS A 189 1 7 HELIX 3 3 GLU A 191 ASN A 204 1 14 HELIX 4 4 LEU A 235 ARG A 243 1 9 HELIX 5 5 SER A 246 GLU A 267 1 22 HELIX 6 6 LYS A 276 GLU A 278 5 3 HELIX 7 7 THR A 312 LEU A 316 5 5 HELIX 8 8 ALA A 317 GLU A 322 1 6 HELIX 9 9 ALA A 329 GLY A 345 1 17 HELIX 10 10 ASP A 353 GLU A 364 1 12 HELIX 11 11 GLY A 373 LEU A 384 1 12 HELIX 12 12 ASP A 398 GLN A 404 1 7 HELIX 13 13 HIS A 405 ALA A 409 5 5 HELIX 14 14 VAL A 412 GLU A 418 1 7 HELIX 15 15 ASP A 439 ALA A 444 1 6 HELIX 16 16 THR B 146 ASN B 148 5 3 HELIX 17 17 LYS B 183 LYS B 189 1 7 HELIX 18 18 GLU B 191 ASN B 204 1 14 HELIX 19 19 LEU B 235 ARG B 243 1 9 HELIX 20 20 SER B 246 GLU B 267 1 22 HELIX 21 21 LYS B 276 GLU B 278 5 3 HELIX 22 22 THR B 312 LEU B 316 5 5 HELIX 23 23 ALA B 317 GLU B 322 1 6 HELIX 24 24 ALA B 329 GLY B 345 1 17 HELIX 25 25 ASP B 353 GLU B 364 1 12 HELIX 26 26 GLY B 373 LEU B 384 1 12 HELIX 27 27 ASP B 398 GLN B 404 1 7 HELIX 28 28 HIS B 405 ALA B 409 5 5 HELIX 29 29 VAL B 412 LYS B 419 1 8 HELIX 30 30 ASP B 439 ALA B 444 1 6 SHEET 1 A 6 PHE A 150 LYS A 158 0 SHEET 2 A 6 GLY A 162 GLU A 169 -1 O LEU A 166 N LYS A 154 SHEET 3 A 6 TYR A 175 LYS A 182 -1 O ILE A 180 N LYS A 163 SHEET 4 A 6 ARG A 222 GLU A 228 -1 O MET A 227 N ALA A 177 SHEET 5 A 6 LEU A 213 GLN A 218 -1 N PHE A 217 O CYS A 224 SHEET 6 A 6 TYR A 474 SER A 475 -1 O TYR A 474 N SER A 216 SHEET 1 B 3 GLY A 233 GLU A 234 0 SHEET 2 B 3 LEU A 280 LEU A 282 -1 O LEU A 282 N GLY A 233 SHEET 3 B 3 ILE A 288 ILE A 290 -1 O LYS A 289 N MET A 281 SHEET 1 C 2 VAL A 270 VAL A 271 0 SHEET 2 C 2 LYS A 297 GLU A 298 -1 O LYS A 297 N VAL A 271 SHEET 1 D 2 CYS A 310 GLY A 311 0 SHEET 2 D 2 PHE C 8 ALA C 9 -1 O PHE C 8 N GLY A 311 SHEET 1 E 6 PHE B 150 LYS B 158 0 SHEET 2 E 6 GLY B 162 GLU B 169 -1 O LEU B 166 N LYS B 154 SHEET 3 E 6 TYR B 175 LYS B 182 -1 O TYR B 176 N VAL B 167 SHEET 4 E 6 ARG B 222 GLU B 228 -1 O LEU B 223 N LEU B 181 SHEET 5 E 6 LEU B 213 GLN B 218 -1 N TYR B 215 O VAL B 226 SHEET 6 E 6 TYR B 474 SER B 475 -1 O TYR B 474 N SER B 216 SHEET 1 F 3 GLY B 233 GLU B 234 0 SHEET 2 F 3 LEU B 280 LEU B 282 -1 O LEU B 282 N GLY B 233 SHEET 3 F 3 ILE B 288 ILE B 290 -1 O LYS B 289 N MET B 281 SHEET 1 G 2 CYS B 310 GLY B 311 0 SHEET 2 G 2 PHE D 8 ALA D 9 -1 O PHE D 8 N GLY B 311 LINK C LYS A 307 N TPO A 308 1555 1555 1.33 LINK C TPO A 308 N PHE A 309 1555 1555 1.33 LINK C LYS B 307 N TPO B 308 1555 1555 1.33 LINK C TPO B 308 N PHE B 309 1555 1555 1.33 SITE 1 AC1 15 GLY A 162 LYS A 163 ALA A 177 LYS A 179 SITE 2 AC1 15 MET A 227 GLU A 228 ALA A 230 GLU A 234 SITE 3 AC1 15 GLU A 278 ASN A 279 MET A 281 THR A 291 SITE 4 AC1 15 ASP A 292 PHE A 438 ARG C 4 SITE 1 AC2 15 GLY B 159 GLY B 162 LYS B 163 VAL B 164 SITE 2 AC2 15 ALA B 177 MET B 227 GLU B 228 ALA B 230 SITE 3 AC2 15 GLU B 278 ASN B 279 MET B 281 THR B 291 SITE 4 AC2 15 ASP B 292 PHE B 438 ARG D 4 CRYST1 86.265 56.013 91.650 90.00 104.27 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011592 0.000000 0.002949 0.00000 SCALE2 0.000000 0.017853 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011259 0.00000